doctoral/PhD student at Department of Medicinal Chemistry, Preparative Medicinal Chemistry
There is a demand for new chemical entities that can serve as efficient agents for treatment of cognitive disorders. Angiotensin IV, a metabolite in the renin angiotensin system, has shown to improve processes related to memory and learning by inhibiting Insulin-regulated Aminopeptidase (IRAP). In my project, we focus on design, synthesis and biological evaluation of novel small-molecule IRAP inhibitors that might provide a new approach in the treatment of memory disfunction.
Also available at
Master's degree in Organic and Medicinal Chemistry, University of Gothenburg, 2012
PhD student at Uppsala University, Department of Medicinal Chemistry, Division of Organic Pharmaceutical Chemistry. 2012 - present.
Please contact the directory administrator for the organization (department or similar) to correct possible errors in the information.